Back to search
FDAFDA · Food and drugs·Recall number D-0518-2024

Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04

Published June 5, 2024 · Recall initiated: May 8, 2024

Summary

FDA records drug Class II recall D-0518-2024, published June 5, 2024 and initiated May 8, 2024. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 51,006 bottles; Lot: Lot #F305184, F305185, F305186, Exp 7/31/ 2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective container: lack of seal integrity.

What to do

Voluntary: Firm initiated · Letter

Get an email if CEFDINIR has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CEFDINIR
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
USA Nationwide
UPC
0368180723042
Lot
Lot #F305184, F305185, F305186, Exp 7/31/ 2025
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cefdinir for Oral Suspension USP, 250 mg/5 mL, packaged in a 60 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, Manufactured by: Lupin Limited, Mandideep, 462 046 India, NDC 68180-723-04 recalled?

Yes. FDA published recall D-0518-2024 on June 5, 2024. Reported hazard: Defective container: lack of seal integrity.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CEFDINIR. UPC: 0368180723042.